Sign inJoin waitlistJoin the waitlist

Geoffrey Gibney

Physician · MedStar Health

Credentials: · · · · · ·

History

MedStar Health
2025–Present

Medical Oncology
2008–2010
Internal Medicine
Boston University Medical Center
2005–2008
University of Connecticut School of Medicine
2001–2005

Research

Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Review · The Lancet Oncology · 2016 · First of 3 authors · Corresponding · 1,377 citations
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Outcomes
Clinical Cancer Research · 2016 · 713 citations

Vernon Sondak
25 papers
JW
Jeffrey Weber
20 papers
Michael Atkins
16 papers
RK
Ragini Kudchadkar
12 papers · 3 as a fellow
Gino In
9 papers
Jane Messina
7 papers
Jeffrey Sosman
7 papers
Jonathan Zager
7 papers
PF
Peter Forsyth
6 papers
Ryan Sullivan
6 papers · 1 as a fellow
Douglas Johnson
5 papers
EB
Elizabeth Buchbinder
5 papers

Grants

Georgetown University Lombardi Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $183.7K · Georgetown University
1997–2029

Clinical trials

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Principal investigator · Active not recruiting · Phase 2
ECOG-ACRIN Cancer Research Group
2021–2030
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Principal investigator · Active not recruiting · Phase 2
Georgetown University
2020–2026